A detailed history of Tfb Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tfb Advisors LLC holds 1,783 shares of ABBV stock, worth $320,940. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,783
Previous 1,724 3.42%
Holding current value
$320,940
Previous $295,000 19.32%
% of portfolio
0.11%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $9,666 - $11,760
59 Added 3.42%
1,783 $352,000
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $16,717 - $19,522
108 Added 6.68%
1,724 $295,000
Q1 2024

May 03, 2024

BUY
$159.82 - $182.1 $258,269 - $294,273
1,616 New
1,616 $294,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $94,314 - $109,182
706 Added 45.23%
2,267 $337,000
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $206,848 - $257,408
1,561 New
1,561 $210,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tfb Advisors LLC Portfolio

Follow Tfb Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfb Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfb Advisors LLC with notifications on news.